Home » Newsletters » BioWorld Science

BioWorld Science

May 27, 2011

View Archived Issues

LIPN gene mutation correlates with late-onset autosomal recessive ichthyosis

HRA Pharma and ASKA Pharmaceutical enter licensing agreement in Japan for ellaOne

Novel phosphodiesterase 10A inhibitors designed

New sponge-derived anticancer polyketides described

Daiichi Sankyo presents novel erythropoietin production enhancers

InterMune provides update on development and commercialization of Esbriet

Oncothyreon begins phase II portion of phase I/II trial of PX-866 with cetuximab

Initiation of phase II study triggers milestone payment from Bristol-Myers Squibb to AMRI

Preclinical data support further development of PF-4348235 for treatment of COPD

Findings disclosed from two phase II trials of NXL-104/ceftazidime

Nexvax-2 vaccine is safe and bioactive in phase I trial in celiac disease

Centella Therapeutics gains exclusive rights to antitumor agent CEN-209

FDA approves IND for phase I trial of PWT-33597

Aastrom and CPC Clinical Research enter agreement for phase III REVIVE program of ixmyelocel-T

FLAME study shows enhanced stroke recovery with fluoxetine

Dynavax completes 12-month follow-up in phase III Heplisav trial

Active Biotech's ABR-215757 improves SLE symptoms in exploratory phase II trial

GSK presents new bromodomain inhibitors

Phase II extension data encouraging for Derma Sciences' DSC-127 in diabetes-related foot ulcers

EV-71 vaccine against hand, foot and mouth disease shows promise in phase I trial

Futurechem presents new beta-amyloid production inhibitors

Lytix Biopharma completes two phase I/IIa trials of topical antimicrobial drug Lytixar

NHLBI stops AIM-HIGH study of niacin added to simvastatin early

Ellavie spray approved in Sweden to treat symptoms of menopause

Zeria presents data showing efficacy of Acofide in treatment of functional dyspepsia

German authorities approve Sativex for treatment of spasticity due to MS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...